Table 3 The post-operative details and follow-up outcomes
Variables | Group 1 | Group 2 | P value |
|---|---|---|---|
Post-hospital stay (days) | 9.1 ± 2.5 | 15.1 ± 3.3 | 0.025 |
Time to oral intake (days) | 1.5 ± 0.7 | 2.1 ± 0.8 | NS |
Overall Complications (n, %) | 11, 40.7% | 12, 34.3% | 0.60 |
Pancreatic fistula | 0.73 | ||
Grade B | 8 (29.6%) | 7 (20%) | |
Grade C | 0 | 0 | - |
Abdominal abscess | 1 (3.7%) | 2 (5.7%) | 1.0 |
Re-operation | 1 (3.7%) | 0 | 1.0 |
Abdominal bleeding | 1 (3.7%) | 0 | 1.0 |
DGE | 0 | 2 (5.7%) | 1.0 |
Bile leakage | 0 | 1 (2.9%) | 1.0 |
Tumor recurrence | 1.0 | ||
Local recurrence | 0 | 0 | |
Metastasis | 0 | 1 (2.9%) | |
Pancreatic function deficiency | |||
Exocrine | 0 | 2 (5.7%) | 1.0 |
Endocrine | 0 | 1 (2.9%) | 1.0 |